ABC
RETA

Associated Banc-Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Associated Banc-Corp’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed -$1K – 933
2020
Q4 		$1K Hold
10
– – ﹤0.01% 963
2020
Q3 		$1K Buy
+10
New +$1.25K ﹤0.01% 960
2020
Q2 		– Sell
-8
Closed -$1K – 1192
2020
Q1 		$1K Buy
+8
New +$1.54K ﹤0.01% 883

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Associated Banc-Corp's RETA Position: Q1 2021 in Review

Associated Banc-Corp sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2021, closing a stake of 10 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in RETA in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 201 funds tracked by Wall St. Rank hold RETA as of Q1 2021.

  • Associated Banc-Corp reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 10 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2020 and held it in 3 quarters.
  • Associated Banc-Corp's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1K in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.